“慢阻肺的优化治疗与革新”研讨会在上海成功召开

• 出 处: 中国新药杂志
• 发表日期: 2016年11期
• 关键词: 噻托溴铵 上海市肺科医院 药剂科 临床疗效 数据统计 刘锦

2016年5月20日,“慢阻肺的优化治疗与革新”研讨会在上海召开。本次研讨会以“慢阻肺的优化治疗与革新”为专题,特邀同济大学附属上海市肺科医院刘锦铭教授做了“噻托溴铵给药装置与临床疗效”的主题报告。来自全国各地的药剂科专家出席了本次研讨会并与演讲专家进行了互动交流。会议取得圆满成功。会上刘锦铭教授介绍了慢阻肺(COPD)在国内外数据统计的发病情况,WHO多年来一直发布全球每年死于慢阻肺的人数超过300万,近几年有研究显示,中国每年死于慢阻肺的人

May 20, 2016, “Optimal treatment and innovation of COPD” was held in Shanghai. The symposium focused on the topic of “Optimal treatment and innovation of COPD”, and invited Professor Liu Jinming from Shanghai Pulmonary Hospital affiliated to Tongji University to give a talk on the theme of “Tiotropium delivery device and clinical efficacy” report. Pharmacy experts from all over the country attended this seminar and conducted speeches with experts. The meeting was a complete success. At the meeting, Professor Liu Jinming introduced the incidence of COPD data statistics at home and abroad. WHO has released more than 3 million people worldwide who die of COPD each year. In recent years, studies have shown that China dies each year Chronic obstructive lung